Graticule Asia Macro Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Graticule Asia Macro Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,600	Closed	-$782K	–	101
2018 Q3	$782K	Buy	12,600 +8,100	+180%	+$481K	0.04%	144
2018 Q2	$249K	Buy	4,500 +900	+25%	+$48.6K	0.02%	143
2018 Q1	$228K	Buy	+3,600	New	+$232K	0.02%	134
2017 Q1	–	Sell	-159,500	Closed	-$8.75M	–	130
2016 Q4	$9.32M	Buy	+159,500	New	+$8.72M	1.12%	25
2015 Q4	–	Sell	-50,000	Closed	-$2.96M	–	174
2015 Q3	$2.96M	Buy	+50,000	New	+$3.17M	0.35%	42

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Graticule Asia Macro Advisors's BMY Position: Q4 2018 in Review

Graticule Asia Macro Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 12,600 shares — an estimated $782K sold.

Graticule Asia Macro Advisors first reported a position in BMY in Q3 2015 and held it in 5 quarters. The position peaked at $9.32M in Q4 2016. 1,765 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Graticule Asia Macro Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
Graticule Asia Macro Advisors sold 12,600 Bristol-Myers Squibb shares in Q4 2018, an estimated $782K.
Graticule Asia Macro Advisors first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 5 quarters.
Graticule Asia Macro Advisors's Bristol-Myers Squibb position peaked at $9.32M in Q4 2016.
1,765 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Graticule Asia Macro Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.